|Bid||1.3100 x 27000|
|Ask||1.3400 x 34100|
|Day's range||1.2700 - 1.4600|
|52-week range||0.6570 - 7.4400|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||16 Mar 2022 - 21 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.00|
Progenity (NASDAQ: PROG), a biotech company and a meme stock favorite, saw its shares decline more than 11% on Wednesday. Overall, Progenity stock is down more than 47% this year. The markets don't like uncertainty, and that's one reason Progenity has trended downward.
Shares of Progenity (NASDAQ: PROG) were up more than 34% on Tuesday. At the time of its initial public offering in 2020, the biotech company went for $13 a share, and the stock has been highly volatile because it is a retail investor favorite. It is the second time in less than a month that Progenity has taken off on a short-squeeze-fueled frenzy.
Progenity, Inc. (PROG) delivered earnings and revenue surprises of 19.15% and -98.36%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?